Delivery Order SPE2DB20D1100-SPE2DB24FB6B1
- Not listed
- This federal contract award, valued at $4,176.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,502,725 units of Bupropion HCL XL 300 mg tablets, a medication used to treat depression. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, valued at $19,173.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order that covers the provision of 4563609487 - Bupropion HCL XL 150 MG Tablet 500S, a pharmaceutical product. This award is not associated with any set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,688.03, is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support...
- This federal contract award, valued at $58,566.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,286,845 units of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and certain other conditions. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $53,758.07 firm fixed-price delivery order is for the supply of Bupropion HCL XL 300 mg tablets to support military and veterans' healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $25,866.44, is for the delivery of Bupropion HCL XL 150 mg tablets over a 2-year period ending in May 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned, indicating an open competition. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,854.28, is for the delivery of Bupropion HCL XL 300 mg tablets over the period ending on January 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,858.87 firm fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets, with a completion date of February 23, 2024. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition. Amerisourcebergen is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,069.10 firm fixed-price delivery order covers the supply of 4554558833 tablets of Bupropion HCL XL 300 mg, a generic medication used to treat depression and smoking cessation. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC...
- This federal contract award, valued at $14,671.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a medication used to treat depression and other conditions. The contract is a firm-fixed-price delivery order with a period of performance through March 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB6B1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $29,534.76 firm-fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets, a generic medication used to treat depression. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation, indicating open competition. The award demonstrates Amerisourcebergen's role as a critical supplier of essential pharmaceutical products to federal government agencies, particularly for military and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.5k | 5/3/24 |